These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26392778)

  • 81. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.
    Enomoto H; Nakamura H; Liu W; Nishiguchi S
    Int J Mol Sci; 2015 Jun; 16(6):14086-97. PubMed ID: 26101867
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The expression and clinical significance of HDGF in osteosarcoma.
    Chen Z; Qiu S; Lu X
    Onco Targets Ther; 2015; 8():2509-17. PubMed ID: 26392778
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer.
    Liu XJ; Liu WL; Yang FM; Yang XQ; Lu XF
    Onco Targets Ther; 2015; 8():2101-9. PubMed ID: 26316779
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin.
    Liu C; Wang L; Jiang Q; Zhang J; Zhu L; Lin L; Jiang H; Lin D; Xiao Y; Fang W; Guo S
    Front Oncol; 2019; 9():211. PubMed ID: 31032220
    [No Abstract]   [Full Text] [Related]  

  • 85. Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
    Liu X; Ma W; Ma J; Xiao L; Hao D
    Pathol Res Pract; 2019 Aug; 215(8):152492. PubMed ID: 31257090
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Advances in emerging drugs for osteosarcoma.
    Hattinger CM; Fanelli M; Tavanti E; Vella S; Ferrari S; Picci P; Serra M
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):495-514. PubMed ID: 26021401
    [TBL] [Abstract][Full Text] [Related]  

  • 88. HDGF: a novel jack-of-all-trades in cancer.
    Bao C; Wang J; Ma W; Wang X; Cheng Y
    Future Oncol; 2014 Dec; 10(16):2675-85. PubMed ID: 25236340
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Osteosarcoma treatment - where do we stand? A state of the art review.
    Luetke A; Meyers PA; Lewis I; Juergens H
    Cancer Treat Rev; 2014 May; 40(4):523-32. PubMed ID: 24345772
    [TBL] [Abstract][Full Text] [Related]  

  • 90. p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour.
    Yang Y; Zhen T; Zhang F; Dai S; Kang L; Liang Y; Xue L; Han A
    J Clin Pathol; 2014 Mar; 67(3):235-42. PubMed ID: 24072730
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.
    Collins M; Wilhelm M; Conyers R; Herschtal A; Whelan J; Bielack S; Kager L; Kühne T; Sydes M; Gelderblom H; Ferrari S; Picci P; Smeland S; Eriksson M; Petrilli AS; Bleyer A; Thomas DM
    J Clin Oncol; 2013 Jun; 31(18):2303-12. PubMed ID: 23669227
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
    Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
    Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Quantitative retinal protein analysis after optic nerve transection reveals a neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion cells.
    Hollander A; D'Onofrio PM; Magharious MM; Lysko MD; Koeberle PD
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3973-89. PubMed ID: 22531700
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.
    Lin YW; Li CF; Chen HY; Yen CY; Lin LC; Huang CC; Huang HY; Wu PC; Chen CH; Chen SC; Tai MH
    Oral Oncol; 2012 Jul; 48(7):629-35. PubMed ID: 22361040
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.